Stanford University: Research to Revenue

University of Washington

Summit Venture Studio

Research to Revenue Report

Summit Venture Studio (SVS) Opportunities

SVS has identified 22 commercialization opportunities from University of Washington and scored them based on our proprietary metrics and rubrics.
The SVS model is to identify the top 1% of commercialization opportunities and start companies around them.
Please connect with SVS if you would like to engage with us in our startup and investment efforts.

SVS Innovation Index

Proprietary Assessment of University of Washington's Innovation Ecosystem
Score out of 100. Benchmark: Top 50 U.S. research institutions.
A score of 90/100 can be read "doing better than 90% of schools benchmarked"

Innovation Visibility

79/100
Definition: Media mentions, publication count, and global research visibility metrics

Innovation Momentum

78/100
Definition: Change in number of patents, grants, and startups over past 3 years

Ecosystem Strength

80/100
Definition: Number of innovation programs, staff count, and partnership initiatives

Innovation Legacy

A Timeline of Groundbreaking Discoveries

Innovation Timeline

1861
Founded
1984
Technology Transfer Office
2013
Clean Energy Institute
2015
oMotion Launched
2017
Global Innovation Exchange
2024
Today

Key Legacy Metrics

12
Nobel Prizes
as of FY2023
293
Spinout Companies Founded
since 1984
8
University Direct Spinouts
from tech transfer office
$1.87B
Annual Research Funding
FY2023

Notable Commercialization Outcomes

Overland AI

Founded 2022, autonomous vehicle navigation technology

Recent Spinout
A-Alpha Bio

Founded 2017, synthetic biology platform

Notable Spinout
Cyrus Biotechnology

Founded 2015, computational protein design

Notable Spinout
Zensi

Energy monitoring technology, acquired by Belkin 2010

Successful Exit

Key Innovation Indicators

N/A
Product Licenses
Data Not Available
N/A
Active Technologies
Data Not Available
N/A
Licensing Revenue
Data Not Available
12.1x
Bridge Funding ROI
Program Average

Innovation Metrics & Output

Research Engine Performance & IP Generation

Most Impactful Patents

High Impact
Cellular Labeling
High Impact
Enhanced Methods
Recent
Polymer Dots

Key patents in cellular and materials science

Federal Funding Breakdown

$558M
NIH (45%)
Healthcare
FY2023
$842M
NSF (68%)
Scientific Research
FY2023
N/A
DOE
Energy
Data N/A
N/A
DoD
Defense
Data N/A

N/A New Inventions Disclosed (Data Not Available)

N/A New Startup Licenses (Data Not Available)

School-Level Research Funding Distribution

$558M
School of Medicine (30%)
Healthcare & Biomedical
FY2023
$30.2M
Bioengineering (2%)
Engineering & Technology
FY2023
$0.9M
Information School (<1%)
Information Sciences
FY2023
$1.28B
Other Schools (68%)
Various Disciplines
FY2023

$1.87B Total External Research Funding (FY2023)

66% Federal Government Sources ($1.23B in FY2020)

University Innovation Analysis

Total Innovation Scores by Institution

Top Universities by Innovation Score

180+ High Innovation
150-179 Strong Innovation
130-149 Moderate Innovation
100-129 Emerging Innovation

130+ total score considered high innovation impact

Competitive Benchmarking

University of Washington vs. Peer Research Universities

University of Washington vs Peers Comparison

Metric U Washington (FY2023) Peer Average Elite Average
Annual R&D Expenditure $1.73B $1.5B $2.2B
New Inventions Disclosed N/A 260 600
Startups Formed 293 10 30
Visibility Index 79 85 90
Licensing Revenue N/A $30M $100M+
Note: Peer Average = Median value among U.S. R1 research universities. Elite Average = Top 10 ranked U.S. research universities.

Research ROI Analysis

12.1x
U Washington
2.0%
Peer Avg
5.0%
Top Performer

Strength: University of Washington's Bridge Funding Program shows exceptional ROI performance

ROI Note: UW Bridge Funding Program shows 12.1-fold return on investment. General licensing ROI data not available.

Emerging Opportunities

iNCOVACC Vaccine Technology
Successfully licensed iNCOVACC vaccine technology in 2022, demonstrating strong potential in biotechnology commercialization.
WE-REACH Program
Established 2019 and awarded NIH grant in 2020, focusing on research translation and commercialization support.